| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbdc68ca0aa38fef2d059853ef2b31e6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
1995-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1996-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eba24e647637f58e09d87d79685e0a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46db05297c6c9e1aad05a06b8f982083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a224d4e83ea538420e43c1178d63fdd |
| publicationDate |
1996-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5525347-A |
| titleOfInvention |
Composition and methods for treating performance anxiety |
| abstract |
The invention provides a pharmaceutical composition for treating performance anxiety and social phobia comprising a therapeutic amount for the treatment of a patient of a β-adrenergic receptor blocking compound and an anti-diaphoretic compound. The preferred β-adrenergic receptor blocking compound is the lipophilic β-blocker propranolol HCL. The anti-diaphoretic compound of the present invention is preferably glycopyrrolate. The composition for treating performance anxiety and social phobia can further include a pharmaceutically acceptable carrier. A method of preventing or treating performance anxiety or social phobia in a patient comprising administering the composition of the invention to a patient in need of such treatment is also provided. The composition administered in the present method comprises a therapeutic amount of a β-adrenergic receptor blocking compound and an anti-diaphoretic compound. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021113260-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3415127-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9926270-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11291651-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11291652-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6500827-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1123098-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014148465-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3473615-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6218395-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6063808-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9610278-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5798393-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8558008-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6433003-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10548875-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008260823-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6395757-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10543192-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10004717-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11542232-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9006461-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9006462-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10294201-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002523458-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3842419-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7022342-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8859610-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011218215-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014134510-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9800109-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1123098-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9259414-B2 |
| priorityDate |
1995-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |